Literature DB >> 2895275

Treatment of myocarditis with OKT3 monoclonal antibody.

E M Gilbert, J B O'Connell, M E Hammond, D G Renlund, F S Watson, M R Bristow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895275     DOI： 10.1016/s0140-6736(88)91555-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Influence of myocarditis on left ventricular function.

Authors:  K L Baughman
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Therapeutic implications of immune mechanisms in myocarditis.

Authors:  J B O'Connell; J W Mason
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Active lymphocytic myocarditis treated with murine OKT3 monoclonal antibody in a patient presenting with intractable ventricular tachycardia.

Authors:  Zofia T Bilinska; Jacek Grzybowski; Tomasz Szajewski; Janina Stepinska; Ewa Michalak; Ewa Walczak; Teresa Wagner; Barbara Kwiatkowska; Witold Ruzyllo
Journal:  Tex Heart Inst J       Date:  2002

Review 4.  Clinical decisions in the management of the cardiomyopathies.

Authors:  J F Goodwin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

5.  Anti-alpha beta T cell receptor antibody prevents the progression of experimental autoimmune myocarditis.

Authors:  H Hanawa; M Kodama; T Inomata; T Izumi; A Shibata; M Tuchida; Y Matsumoto; T Abo
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.